ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,349Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 761

$427K Total Retail Price of All Prescriptions

Rank: 184 out of 761

585 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 585 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

9% of this provider’s 585 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 9,565 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 559 522 1 1
LEVOTHYROXINE SODIUM 446 439 2 3
AMLODIPINE BESYLATE 383 366 3 6
SIMVASTATIN 346 322 4 2
METFORMIN HCL 346 303 4 10
OMEPRAZOLE 305 267 6 4
ATENOLOL 302 263 7 8
PAROXETINE HCL 289 254 8 47
PRAVASTATIN SODIUM 250 230 9 20
WARFARIN SODIUM 238 238 10 9
FUROSEMIDE 222 198 11 7
METOPROLOL SUCCINATE 222 222 11 16
HYDROCHLOROTHIAZIDE 207 203 13 11
HYDROCODONE-ACETAMINOPHEN 194 152 S3 14 5
AZITHROMYCIN 176 159 15 70
TRAMADOL HCL 176 161 15 34
POTASSIUM CHLORIDE 159 147 17 18
METOPROLOL TARTRATE 159 157 17 14
ATORVASTATIN CALCIUM 140 132 19 12
TRAZODONE HCL 118 103 20 23
TAMSULOSIN HCL 113 100 21 27
ALLOPURINOL 108 96 22 28
CITALOPRAM HBR 105 101 23 19
QUINAPRIL HCL 101 101 24 156
GABAPENTIN 100 80 25 15
GLYBURIDE 98 90 R 26 77
LOVASTATIN 98 98 26 17
ZOLPIDEM TARTRATE 92 92 28 22
GLIMEPIRIDE 88 74 29 48
DIGOXIN 88 88 29 43
PANTOPRAZOLE SODIUM 81 81 31 40
BENICAR 79 76 32 81
SPIRIVA 79 79 32 56
CARBIDOPA-LEVODOPA 76 76 34 82
FLUTICASONE PROPIONATE 75 70 35 29
PROAIR HFA 75 64 35 32
PREDNISONE 72 69 37 30
ADVAIR DISKUS 71 71 38 37
LOSARTAN POTASSIUM 69 66 39 13
ALENDRONATE SODIUM 68 68 40 21
CLOPIDOGREL 65 62 41 66
METFORMIN HCL ER 59 59 42 67
TRIAMTERENE-HCTZ 56 54 43 42
TRIAMCINOLONE ACETONIDE 56 55 43 84
TERAZOSIN HCL 54 54 45 86
PLAVIX 50 50 46 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.